Massimiliano Gnecchi

Massimiliano Gnecchi

Auto-generated profile, based on publicly available information

Massimiliano Gnecchi

Translational Cardiology Unit Fondazione IRCCS Policlinico San Matteo Pavia Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2008 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MGMassimiliano Gnecchi
Massimiliano Gnecchi
ZZZhiping Zhang
Zhiping Zhang
ANAiguo Ni
Aiguo Ni
VDVictor J. Dzau
Victor J. Dzau
Animal and preliminary human studies of adult cell therapy following acute myocardial infarction have shown an overall improvement of cardiac function. Myocardial and vascular regeneration have been initially proposed as mechanisms of stem cell action. However, in many cases, the frequency of stem cell engraftment and the number of newly generated cardiomyocytes and vascular cells, either by transdifferentiation or cell fusion, appear too low to explain the significant cardiac improvement described. Accordingly, we and others have advanced an alternative hypothesis: the transplanted stem cells release soluble factors that, acting in a paracrine fashion, contribute to cardiac repair and regeneration. Indeed, cytokines and growth factors can induce cytoprotection and neovascularization. It has also been postulated that paracrine factors may mediate endogenous regeneration via activation of resident cardiac stem cells. Furthermore, cardiac remodeling, contractility, and metabolism may also be influenced in a paracrine fashion. This article reviews the potential paracrine mechanisms involved in adult stem cell signaling and therapy.

1 April 2005 in Nature Medicine
Verified
Journal Article
Closed access
MGMassimiliano Gnecchi
Massimiliano Gnecchi
HHHuamei He
Huamei He
OLOlin D Liang
Olin D Liang
LMLuis G Melo
Luis G Melo
FMFulvio Morello
Fulvio Morello
VDVictor J Dzau
Victor J Dzau

1 April 2006 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MGMassimiliano Gnecchi
Massimiliano Gnecchi
HHHuamei He
Huamei He
NNNicolas Noiseux
Nicolas Noiseux
OLOlin D. Liang
Olin D. Liang
LZLunan Zhang
Lunan Zhang
VDVictor J. Dzau
Victor J. Dzau
We previously reported that intramyocardial injection of bone marrow‐derived mesenchymal stem cells overexpressing Akt (Akt‐MSCs) inhibits ventricular remodeling and restores cardiac function measured 2 wk after myocardial infarction. Here, we report that the functional improvement occurs in < 72 h. This early remarkable effect cannot be readily attributed to myocardial regeneration from the donor cells. Thus, we hypothesized that paracrine actions exerted by the cells through the release of soluble factors might be important mechanisms of tissue repair and functional improvement after injection of the Akt‐MSCs. Indeed, in the current study we demonstrate that conditioned medium from hypoxic Akt‐MSCs markedly inhibits hypoxia‐induced apoptosis and triggers vigorous spontaneous contraction of adult rat cardiomyocytes in vitro . When injected into infarcted hearts, the Akt‐MSC conditioned medium significantly limits infarct size and improves ventricular function relative to controls. Sup‐port to the paracrine hypothesis is provided by data showing that several genes, coding for factors (VEGF, FGF‐2, HGF, IGF‐I, and TB4) that are potential mediators of the effects exerted by the Akt‐MSC conditioned medium, are significantly up‐regulated in the Akt‐MSCs, particularly in response to hypoxia. Taken together, our data support Akt‐MSC‐mediated para‐crine mechanisms of myocardial protection and functional improvement.‐Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J. S., Dzau, V. J. Evidence supporting paracrine hypothesis for Akt‐modified mes‐enchymal stem cell‐mediated cardiac protection and functional improvement. FASEB J. 20, 661–669 (2006)

30 January 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MMMaria Mirotsou
Maria Mirotsou
ZZZhongyan Zhang
Zhongyan Zhang
ADArjun Deb
Arjun Deb
LZLunan Zhang
Lunan Zhang
MGMassimiliano Gnecchi
Massimiliano Gnecchi
VDVictor Dzau
Victor Dzau
Stem cell therapy has emerged as a promising tool for the treatment of a variety of diseases. Previously, we have shown that Akt-modified mesenchymal stem cells mediate tissue repair through paracrine mechanisms. Using a comprehensive functional genomic strategy, we show that secreted frizzled related protein 2 (Sfrp2) is the key stem cell paracrine factor that mediates myocardial survival and repair after ischemic injury. Sfrp2 is known to modulate Wnt signaling, and we demonstrate that cardiomyocytes treated with secreted frizzled related protein increase cellular β-catenin and up-regulate expression of antiapoptotic genes. These findings reveal the key role played by Sfrp2 in mediating the paracrine effects of Akt-mesenchymal stem cells on tissue repair and identify modulation of Wnt signaling as a therapeutic target for heart disease.

1 February 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MMMaria Mirotsou
Maria Mirotsou
TJTilanthi M. Jayawardena
Tilanthi M. Jayawardena
JSJeffrey Schmeckpeper
Jeffrey Schmeckpeper
MGMassimiliano Gnecchi
Massimiliano Gnecchi
VDVictor J. Dzau
Victor J. Dzau

1 December 2006 in Molecular Therapy
Verified
Journal Article
Open access
NNNicolas Noiseux
Nicolas Noiseux
MGMassimiliano Gnecchi
Massimiliano Gnecchi
MLMarco Lopez-Ilasaca
Marco Lopez-Ilasaca
LZLunan Zhang
Lunan Zhang
SSScott D. Solomon
Scott D. Solomon
RPRichard E. Pratt
Richard E. Pratt
We previously reported that intramyocardial injection of bone marrow-derived mesenchymal stem cells overexpressing Akt (MSC-Akt) efficiently repaired infarcted rat myocardium and improved cardiac function. Controversy still exists over the mechanisms by which MSC contribute to tissue repair. Herein, we tested if cellular fusion of MSC plays a determinant role in cardiac repair. We injected MSC expressing Cre recombinase, with or without Akt, into Cre reporter mice. In these mice, LacZ is expressed only after Cre-mediated excision of a loxP-flanked stop signal and is indicative of fusion. MSC engraftment within infarcted myocardium was transient but significantly enhanced by Akt. MSC fusion with cardiomyocytes was observed as early as 3 days, but was infrequent, and we found a low rate of differentiation of MSC into cardiomyocytes. MSC-Akt decreased infarct size at 3 days and restored early cardiac function. In conclusion, MSC-Akt improved early repair despite transient engraftment, low levels of cellular fusion, and differentiation. These new observations further confirm our recently reported data that early paracrine mechanisms mediated by MSC are responsible for enhancing the survival of existing myocytes and that Akt could alter the secretion of various cytokines and growth factors.